Related references
Note: Only part of the references are listed.Monitoring of Thiopurine Metabolites in Patients With Inflammatory Bowel Disease-What Is Actually Measured?
Svante Vikingsson et al.
THERAPEUTIC DRUG MONITORING (2009)
Long-term outcome of using allopurinol co-therapy as a strategy for overcoming thiopurine hepatotoxicity in treating inflammatory bowel disease
A. Ansari et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: A review
Javier P. Gisbert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Stability of thiopurine metabolites: A potential analytical bias
Peer de Graaf et al.
CLINICAL CHEMISTRY (2008)
Dose-dependent influence of 5-aminosalicylates on thiopurine metabolism
Nanne K. H. de Boer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD
Nanne K. H. de Boer et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2007)
Adherence to thiopurine treatment in out-patients with Crohn's disease
B. Bokemeyer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine
Miles P. Sparrow et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine
Karin Dilger et al.
THERAPEUTIC DRUG MONITORING (2007)
Thiopurine treatment in inflammatory bowel disease - Clinical pharmacology and implication of pharmacogenetically guided dosing
Alexander Teml et al.
CLINICAL PHARMACOKINETICS (2007)
Indications for 5-aminosalicylate in inflammatory bowel disease: Is the body of evidence complete?
Ad A. van Bodegraven et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: A meta-analysis
MT Osterman et al.
GASTROENTEROLOGY (2006)
5-Aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine
S Hande et al.
INFLAMMATORY BOWEL DISEASES (2006)
Azathioprine suppresses ezrin-radixin-moesin-dependent T Cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac protein
D Poppe et al.
JOURNAL OF IMMUNOLOGY (2006)
6-thioguanosine diphosphate and triphosphate levels in red blood cells and response to azathioprine therapy in Crohn's disease
MF Neurath et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
The pharmacokinetic effect of discontinuation of mesalazine on mercaptopurine metabolite levels in inflammatory bowel disease patients
LPL Gilissen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Effects of aminosalicylates on thiopurine S-methyltransferase activity:: an ex vivo study in patients with inflammatory bowel disease
H Xin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants
E Schaeffeler et al.
PHARMACOGENETICS (2004)
Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease - Implications for therapy
LJJ Derijks et al.
THERAPEUTIC DRUG MONITORING (2004)
The pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis
WJ Sandborn et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease:: impact of thiopurine S-methyltransferase polymorphism
M Schwab et al.
PHARMACOGENETICS (2002)
6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease
MC Dubinsky et al.
GASTROENTEROLOGY (2002)
Interaction between azathioprine and aminosalicylates: an in vivo study in patients with Crohn's disease
O Dewit et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide
PW Lowry et al.
GUT (2001)
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy
JF Colombel et al.
GASTROENTEROLOGY (2000)
Share Paper
